Managed Healthcare Executive® State of Industry Survey: Addressing Health Disparities Seen As a Long Haul
Results of our survey show some tempering of expectation for addressing healthcare disparities and what can be accomplished this year.
The COVID-19 pandemic and the police killing of George Floyd brought long-simmering issues of disparities in health and healthcare to a boil in 2020. There have been countless numbers of reports, studies, talks and programs since, and the Biden administration has made addressing healthcare disparities a priority.
But results of our annual State of Industry show that the ascendant aspirations for addressing healthcare disparities may be plateauing.
Almost half (45%) of the 100 respondents to our survey indicated agreement with the statement that addressing healthcare disparities is admirable but will take a long time to demonstrate an effect and 17% indicated agreement with the statement that addressing healthcare disparities is admirable, but chances of success are small. On the other hand, a large minority (43%) indicated that they agree that addressing them is long overdue.
More evidence of the hopes for addressing healthcare disparities are coming down to earth: A slim majority (51%) of the respondents indicated that they don’t foresee their organization taking meaningful steps to address healthcare disparities in 2022. And a sizable minority (42%) indicated they had very low or low expectations for the focus on healthcare disparities resulting in meaningful change in 2022.
Premiums for Employer-based Health Insurance Increased by 7% in 2024, Says KFF Report
Published: October 9th 2024 | Updated: October 9th 2024The 2024 increase is the same as last year's increase for family coverage. The foundation’s annual survey of employer health benefits also found that only 18% of large employers (200 employees are more) are covering the GLP-1 weight loss drugs.
Read More
Florida Gets the OK. But Will Drug Importation from Canada Actually Happen?
March 5th 2024Canadian health officials warn that maintaining a drug supply for Canadians is their priority. The staunch opposition of the U.S. pharmaceutical industry may also be an obstacle to imports from north of the border.
Read More
Doug Chaet of Value Evolutions Discusses Value-based Payment Models, Where They Stand and More
September 29th 2022In this episode of Tuning In to the C-Suite, Managing Editor of Managed Healthcare Executive, Peter Wehrwein, speaks with President of Value Evolutions and MHE Editorial Advisory Board Member, Doug Chaet, FACHE, about value-based care's current standing, the status of select payment models like bundled and episodic, and more.
Listen
Parity for Mental Health — Any Progress?
October 12th 2023Laws since 1996 have sought to assure that coverage of behavioral health treatments does not take a back seat to physical medicine. Amid a national crisis in mental illness and addiction, that new world of equality has not arrived. But is it on the way?
Read More
